BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210104
DTEND;VALUE=DATE:20210130
DTSTAMP:20260609T131341
CREATED:20201215T003656Z
LAST-MODIFIED:20201215T004101Z
UID:1661-1609718400-1611964799@thebiocalendar.com
SUMMARY:JPM MONTH - Get the premier guide\, On Your Mark 2021
DESCRIPTION:January 2021\, the Month of the J.P. Morgan Healthcare Conference\n\nSAN FRANCISCO\, CA–(December 14\, 2020)–Big4Bio\, the leading news aggregator service for the top biotech hubs in the United States\, proudly announces the publishing of the 5th edition of On Your Mark\, a compendium of virtual investor and partnering events revolving around the 39th Annual J.P. Morgan Healthcare Conference (#JPM2021). \n“Due to COVID-19 and all events moving to virtual\, what is usually ‘JPM Week’ is essentially ‘JPM Month” for 2021\,” says Tilton Little\, publisher of Big4Bio. “No longer restricted by space\, costs\, and other constraints\, organizations are using the entire month to cater to a diverse audience of industry stakeholders worldwide\, with the J.P. Morgan Healthcare Conference right in the center of everything.” \n“Attending these events is a must for many in the business of biopharma and healthcare\,” says Tilton Little\, publisher of Big4Bio. “From the ACCESS CHINA sessions beginning January 4 to MassBio’s inaugural ‘Partnering Week’ on January 25-29\, this year’s special ‘JPM Month’ has something for everyone in the industry\, and ‘On Your Mark’ will assist all attendees in this brave new virtual world.” \nDOWNLOAD ON YOUR MARK 2021 NOW
URL:https://thebiocalendar.com/event/jpm-month-get-the-premier-guide-on-your-mark-2021/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/12/oym2021cover.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210106
DTEND;VALUE=DATE:20210116
DTSTAMP:20260609T131341
CREATED:20201125T194055Z
LAST-MODIFIED:20201125T194055Z
UID:1621-1609891200-1610755199@thebiocalendar.com
SUMMARY:Solebury Trout Virtual Management Access Event 2021
DESCRIPTION:Please join Solebury Trout for virtual meetings with life science companies January 6-15\, 2020\, starting a week prior to the JPM Healthcare Conference to ensure optimal flexibility. Meetings will be organized via Zoom and can be scheduled back-to-back or more spread out depending on preferences. Solebury Trout handles outreach\, scheduling\, and related logistics with our proprietary CRM\, in which meetings requests can be reviewed\, and schedules can be managed in real time. Thank you for your interest and please contact us with any questions.
URL:https://thebiocalendar.com/event/solebury-trout-virtual-management-access-event-2021/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210108
DTEND;VALUE=DATE:20210111
DTSTAMP:20260609T131341
CREATED:20201024T003629Z
LAST-MODIFIED:20201107T155043Z
UID:1090-1610064000-1610323199@thebiocalendar.com
SUMMARY:InnovatorMD Global Summit 2021
DESCRIPTION:IGS2021 – The Largest Event in the World for Physician Innovators!\nThe largest event of its kind in the world! 3 days of talks\, startup presentations\, keynotes\, workshops\, product demos\, investor pitches\, and networking in a fun\, COVID-safe environment. All focused on physician innovation.
URL:https://thebiocalendar.com/event/innovatormd-global-summit-2021/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/IGS2021-Event-Image.webp-978×548-Google-Chrome-e1603474566972.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210108T080000
DTEND;TZID=UTC:20210108T180000
DTSTAMP:20260609T131341
CREATED:20201024T014529Z
LAST-MODIFIED:20201107T153739Z
UID:1108-1610092800-1610128800@thebiocalendar.com
SUMMARY:6th Annual Dermatology Summit
DESCRIPTION:The mission of the Dermatology Summit is to build a community of people who are excited about innovation in dermatology. \nThis conference uniquely brings together members of the financial community and business leaders from established and emerging companies in the dermatology space to help foster investment and partnerships in the next generation of dermatology companies and products.
URL:https://thebiocalendar.com/event/6th-annual-dermatology-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/logo-ds-index.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210110
DTEND;VALUE=DATE:20210111
DTSTAMP:20260609T131341
CREATED:20201024T011253Z
LAST-MODIFIED:20201107T154951Z
UID:1096-1610236800-1610323199@thebiocalendar.com
SUMMARY:China Showcase 2021
DESCRIPTION:China Showcase\, where Capitalizes on cross-border opportunities during the busiest week in healthcare. With over a decade of experience in China\, we have the largest network of life sciences executives\, investors and BD professionals.
URL:https://thebiocalendar.com/event/china-showcase-2021/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/10/China-Digital-Main-Image-Web-4-f72c913a94f7e70c294f2dc44a985317.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210110
DTEND;VALUE=DATE:20210111
DTSTAMP:20260609T131341
CREATED:20210110T160000Z
LAST-MODIFIED:20201107T013004Z
UID:674-1610236800-1610323199@thebiocalendar.com
SUMMARY:2021 CTIC 5th Annual Healthcare Investment Summit
DESCRIPTION:
URL:https://thebiocalendar.com/event/2021-ctic-5th-annual-healthcare-investment-summit/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210110T080000
DTEND;TZID=UTC:20210110T150000
DTSTAMP:20260609T131341
CREATED:20200926T001942Z
LAST-MODIFIED:20201107T160020Z
UID:665-1610265600-1610290800@thebiocalendar.com
SUMMARY:2021 CERSI Innovations in Regulatory Science Summit
DESCRIPTION:The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the inaugural Innovations in Regulatory Science Summit\, a gathering of leaders in the academia\, industry and regulatory sectors to discuss the role of regulatory science in medical product development. This event will take place before the 2020 J.P. Morgan Healthcare Conference\, and will comprise primarily of panel discussions and short research talks by CERSI investigators on ongoing collaborative research projects with FDA investigators.  Keynotes will be given by Janet Woodcock and Peter Marks from the U.S. Food and Drug Administration. \nPanel topics include: \n\nAccelerating Clinical Trials in the Development and Approval of Innovative Medical Products\nAcademia\, Government and Industry in Regulatory Science: Cross-Sector Collaboration and Avoiding Conflicts of Interest\nReal-World Evidence\, Artificial Intelligence and Novel Medical Devices\nAdvancing Discovery to First-In-Human Clinical Trials for New Medical Products\nConfirmed Speakers\nAmy Abernethy (FDA)\nHal Barron (GlaxoSmithKline)\nDiana Brenner (Gilead)\nBrook Byers (Kleiner Perkins)\nRobert Califf (Verily)\nJennifer Cochran (Stanford)\nJoe Derisi (UCSF)\nMartha Donoghue (FDA)\nLaura Esserman (UCSF)\nKathy Giacomini (UCSF)\nSam Hawgood (UCSF)\nDenise Hinton (FDA)\nPeter Kim (Stanford)\nNevan Krogan (UCSF)\nMathai Mammen (Janssen)\nPeter Marks (FDA)\nMark McClellan (Duke)\nAndy Plump (Takeda)\nGeorge Scangos (Vir)\nJason Sello (UCSF)\nJeff Shuren (FDA)\nKuldev Singh (Stanford)\nJohn Tsai (Novartis)\nLeslie Wilson (UCSF)\nAnne Wojcicki (23andMe)\nJanet Woodcock (FDA)\nGeorge Yancopoulos (Regeneron)
URL:https://thebiocalendar.com/event/innovations-in-regulatory-science-summit/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/09/small_poster.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210115
DTSTAMP:20260609T131341
CREATED:20201107T162345Z
LAST-MODIFIED:20201107T162345Z
UID:1287-1610323200-1610668799@thebiocalendar.com
SUMMARY:H.C. Wainwright BioConnect 2021 Conference
DESCRIPTION:Join us for presenting companies\, fireside discussions\, meetings with H.C. Wainwright investment banking & research teams\, and an evening of virtual entertainment.
URL:https://thebiocalendar.com/event/h-c-wainwright-bioconnect-2021-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210116
DTSTAMP:20260609T131341
CREATED:20201107T163037Z
LAST-MODIFIED:20201109T053844Z
UID:1290-1610323200-1610755199@thebiocalendar.com
SUMMARY:BIO Partnering at JPM
DESCRIPTION:BIO One-on-One Partnering is your virtual partnering and business development companion\, with integrated video conferencing and more biotechnology-specific search filters & therapeutic categories than any other major platform to help you target potential partners faster than ever.  Learn more about BIO One-on-One Partnering → \nParticipating in BIO @ JPM Week provides you access to the biotech business partnering system that set the Guinness World Record in its category. BIO provides this service as the non-profit trade association representing the entire biotechnology community with access available to BIO members and non-members alike.
URL:https://thebiocalendar.com/event/bio-partnering-at-jpm/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/11/JPM-MSC-Partnering-e1604871453141.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210114
DTSTAMP:20260609T131341
CREATED:20201125T193911Z
LAST-MODIFIED:20201125T193911Z
UID:1619-1610323200-1610582399@thebiocalendar.com
SUMMARY:Fierce JPM Week 2021
DESCRIPTION:2020 is history: Where do pharma and healthcare go from here? \nEvery January\, the J.P. Morgan Healthcare Conference in San Francisco has been a news-breaking\, people-watching\, dealmaking bazaar that sets the tone for the year to come—and Fierce has brought together a who’s who of experts and executives on the sidelines. This year\, the meeting’s virtual\, and we will be too\, with a program that goes beyond the cutting-edge panel discussions we’re known for. In CEO interviews\, daily news recaps\, and virtual roundtables\, we’ll explore biopharma’s ongoing work to combat COVID-19—and to fight the world’s other diseases at the same time. \nWe have a strong focus on networking at our event this year. Using our virtual event platform Brella\, attendees can schedule one on one meetings and participate in group chats with speakers\, partners and attendees.
URL:https://thebiocalendar.com/event/fierce-jpm-week-2021/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210116
DTSTAMP:20260609T131341
CREATED:20201125T194220Z
LAST-MODIFIED:20201125T194220Z
UID:1622-1610323200-1610755199@thebiocalendar.com
SUMMARY:French Delegation @ J.P. Morgan Healthcare Conference
DESCRIPTION:This year\, as part of the virtual version of  J.P. Morgan Week\, our team of Life Sciences & Healthcare experts will support French companies during this investor week. \nWith a privileged and discounted access to the main events of the week\, introductions to investors\, masterclasses and a pitch session with international players in the pharmaceutical\, biotech & medtech industries\, Business France & its partners will allow you to navigate efficiently the event and get the most of J.P. Morgan Week.
URL:https://thebiocalendar.com/event/french-delegation-j-p-morgan-healthcare-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210114
DTSTAMP:20260609T131341
CREATED:20201024T024312Z
LAST-MODIFIED:20201110T071023Z
UID:1121-1610323200-1610582399@thebiocalendar.com
SUMMARY:Digital RESI San Francisco 2021
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
URL:https://thebiocalendar.com/event/digital-resi-san-francisco-2021/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/10/Digital-RESI-JPM-3-Day-1100-e1603482138436.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210115
DTSTAMP:20260609T131341
CREATED:20210111T170000Z
LAST-MODIFIED:20201109T054216Z
UID:1116-1610323200-1610668799@thebiocalendar.com
SUMMARY:J.P. Morgan 39th Annual Healthcare Conference (#JPM2021)
DESCRIPTION:The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry\, bringing together industry leaders\, emerging fast-growth companies\, innovative technology creators\, and members of the investment community.
URL:https://thebiocalendar.com/event/j-p-morgan-39th-annual-healthcare-conference-2021/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210111
DTEND;VALUE=DATE:20210116
DTSTAMP:20260609T131341
CREATED:20210111T160000Z
LAST-MODIFIED:20201029T195453Z
UID:1110-1610323200-1610755199@thebiocalendar.com
SUMMARY:2021 Biotech Showcase
DESCRIPTION:Biotech Showcase: San Francisco’s Exclusive Investor and Networking Event – Innovation meets money during biotech’s most impactful week of the year. \nBiotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to\, and meet with\, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. \nThe program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry- and time-relevant topics\, as well as presentations from both private and public companies. \nBenefits \nStand out and position your company among the leaders in biotech/pharma\nCapture attention by showcasing new products\, tools and services\nImprove visibility with prospective licensing and research partners\nEngage into informal meetings and networking \nAbout Demy-Colton Life Science Advisors: \nDemy-Colton Life Sciences Advisors produces highly specialized targeted investor and business conferences exclusively for the biopharmaceutical and life sciences industry. With a proven track
URL:https://thebiocalendar.com/event/2021-biotech-showcase-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/BTS-EMAIL-BANNER.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210111T080000
DTEND;TZID=UTC:20210111T170000
DTSTAMP:20260609T131341
CREATED:20210111T174934Z
LAST-MODIFIED:20210111T174934Z
UID:1681-1610352000-1610384400@thebiocalendar.com
SUMMARY:4th World Chemistry Conference And Exhibitions
DESCRIPTION:The first edition of World Chemistry Conference and Exhibition (WCCE) was born in Rome\, Italy aiming to serve as a premier forum for the presentation of technological advances and research results in the fields of chemistry\, engineering and applied sciences. The second edition WCCE was held in Valencia\, Spain in July of 2018. The third edition was held in Brussels (European Capital)\, Belgium in June of 2019\, and the fourth edition World Chemistry Conference and Exhibition (WCCE-2021) is going to be held in world class city of London in October 04-06\, 2021. With the successful experience of the last three years in Rome (Italy)\, Valencia (Spain)\, and Brussels (Belgium)\, we truly believe that WCCE- 2021 will achieve greater success and provide a better platform for all the participants to have fruitful discussions and to share ideas of researches. With high standard and high quality submissions and presentations in WCCE-2021\, it will one day become a leading conference in this specific academic area. \nIt will feature invited keynote speeches\, peer-reviewed paper presentations\, and academic visit. This conference provides opportunities for the delegates to exchange new ideas and application experiences face to face\, to establish business or research relations and to find global partners for future collaboration.
URL:https://thebiocalendar.com/event/4th-world-chemistry-conference-and-exhibitions-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210113
DTEND;VALUE=DATE:20210115
DTSTAMP:20260609T131341
CREATED:20201108T011808Z
LAST-MODIFIED:20201108T011808Z
UID:1309-1610496000-1610668799@thebiocalendar.com
SUMMARY:34th EAST Annual Scientific Assembly – Virtual Advancing Science
DESCRIPTION:The 34th EAST Annual Scientific Assembly – Virtual #EAST2021 will include more than 50 scientific paper presentations and named lectures. Mark your calendar for this two-day program that will feature excellent science and educational sessions. CME will be available. \nRegistration will open in December\, 2020.  Acknowledging the financial impact on nearly all healthcare systems\, registration pricing has been reduced in an effort to ease some of the financial burden for attendees.
URL:https://thebiocalendar.com/event/34th-east-annual-scientific-assembly-virtual-advancing-science/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210113T080000
DTEND;TZID=UTC:20210113T160000
DTSTAMP:20260609T131341
CREATED:20210113T160000Z
LAST-MODIFIED:20201107T013539Z
UID:900-1610524800-1610553600@thebiocalendar.com
SUMMARY:16th Annual Non-Dilutive Funding Summit
DESCRIPTION:The 16th Annual Non-Dilutive Funding Summit is a free educational\, all-day event that brings together hundreds of life science industry leaders to learn from various non-dilutive funding sources about their interests\, goals\, and funding objectives.
URL:https://thebiocalendar.com/event/16th-annual-non-dilutive-funding-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/FreeMind-Logo-New-enfold-e1602146243612.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210115
DTEND;VALUE=DATE:20210118
DTSTAMP:20260609T131341
CREATED:20201107T154120Z
LAST-MODIFIED:20201107T154120Z
UID:1276-1610668800-1610927999@thebiocalendar.com
SUMMARY:The Gastrointestinal Cancers Symposium
DESCRIPTION:The health and safety of the global oncology community and the patients we serve remains our top priority. As concerns and uncertainty regarding the safety of individual travel and large group gatherings related to the COVID-19 pandemic continue\, the Gastrointestinal Cancers Symposium cosponsors have decided to host the 2021 meeting as a virtual event January 15-17\, 2021. \nThe virtual Symposium will deliver the latest science and multidisciplinary educational content in GI cancers\, including COVID-19’s impact on practice and research. The event will offer an interactive and engaging education program\, including a virtual forum for discussing novel ideas\, practice updates\, and treatment advances. View the program. \nWith more inspiring ways to learn\, more multidisciplinary perspectives\, and more ways to connect with the global oncology community\, the 2021 GI Symposium cosponsors look forward to delivering a robust program that continues to propel the field of GI cancers forward. \nRegister today to join thought leaders from around the world for a new virtual experience. The early registration deadline is December 16 at 11:59 PM (ET). \nShould you have any questions\, please contact us at meetings@asco.org.
URL:https://thebiocalendar.com/event/the-gastrointestinal-cancers-symposium/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210119
DTEND;VALUE=DATE:20210122
DTSTAMP:20260609T131341
CREATED:20201107T225658Z
LAST-MODIFIED:20201107T225659Z
UID:1307-1611014400-1611273599@thebiocalendar.com
SUMMARY:PepTalk 2021
DESCRIPTION:Continuing 20 Years of Advanced Protein Science and Innovation \nWhile a lot has changed since PepTalk was launched in 2001\, our number one goal has always been the same – To serve and unite the biotherapeutics community. \nAs we celebrate our 20th year\, we are excited to offer a fully integrated virtual event that will continue to serve as a content hub for the latest research and biotherapeutics developments\, provide a 1:1 networking platform\, offer an interactive exhibit hall\, live Q&A sessions\, breakout groups\, research posters\, and so much more.
URL:https://thebiocalendar.com/event/peptalk-2021/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/11/chi_peptalk_logo.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210119T083000
DTEND;TZID=UTC:20210119T123000
DTSTAMP:20260609T131341
CREATED:20201223T024048Z
LAST-MODIFIED:20201223T024050Z
UID:1665-1611045000-1611059400@thebiocalendar.com
SUMMARY:PBSS Free Online Symposium: RNAi Therapeutics: Discovery\, Preclinical and Clinical Development
DESCRIPTION:RNA interference (RNAi) therapeutics are emerging as an important class of human medicines due to their ability to harness a natural cellular mechanism that can potentially regulate the expression of any RNA transcript. The first RNAi therapeutics recently entered commercial stage after gaining regulatory approval\, and several others are currently in late stage clinical development. The successful translation of this promising concept into a therapeutic reality has been fundamentally enabled by the development of technologies for safe and efficient delivery of short interfering RNAs (siRNAs) to the target cells. The discovery\, preclinical and clinical development of such technologies will be discussed in this symposium.
URL:https://thebiocalendar.com/event/pbss-free-online-symposium-rnai-therapeutics-discovery-preclinical-and-clinical-development/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2020/12/PBSS-logo-International.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210120
DTEND;VALUE=DATE:20210122
DTSTAMP:20260609T131341
CREATED:20201109T045523Z
LAST-MODIFIED:20201109T050213Z
UID:1328-1611100800-1611273599@thebiocalendar.com
SUMMARY:Onco Cell Therapy Summit
DESCRIPTION:Following the success of our first digital event in July with the likes of Carl June leading the keynote\, the Onco Cell Therapy Summit is returning in its most interactive form ever with 20+ panel conversations\, townhall meetings\, roundtable sessions and coffee break style networking. \nThe Global Onco Cell Therapy Summit is an online event\, January 19th – 21st\, that provides a platform for information sharing to enable the discovery\, translation and commercialization of cell therapies in oncology by connecting senior representatives in pharma\, biotechs and academia. The summit will address the research\, regulatory\, logistical and technical challenges that are holding back the field. \nDelve into how thought leaders in cell therapy are addressing threats and opportunities to bring effective therapies to the market through: \n\nMeeting efficacies and safety targets as well as the scale of demands.\nDiscovering the latest advances in the journey towards effective allogeneic and solid tumor targeting therapies.\nOvercoming the challenging in scale up and automation of manufacturing\nRound table discussions on vectors and the promise of non-viral approaches.\nReimbursment strategies and their link to the latest developments in safety trials and regulatory standards\n\nWhilst bringing together the key decision makers for oncological cell therapies\, this year’s summit will have an added focus on the data releases and mergers that are driving the surge of interest in harnessing alternative cell therapies in cancer treatments. \n\n\n\n\nDownload agenda 
URL:https://thebiocalendar.com/event/onco-cell-therapy-summit/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/11/octs_eu_square_logo_for_website_atf.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210125
DTEND;VALUE=DATE:20210128
DTSTAMP:20260609T131341
CREATED:20201111T002115Z
LAST-MODIFIED:20201111T002117Z
UID:1363-1611532800-1611791999@thebiocalendar.com
SUMMARY:PMWC COVID
DESCRIPTION:The COVID-19 pandemic makes it necessary for leading experts from across disciplines and geographies to come together to jointly address the challenges we are facing when coping with the disruptive nature of the coronavirus SARS-CoV-2 pandemic is having on our healthcare system and our society as a whole. The tasks upon us are enormous and include besides decoding the virus and scaling diagnostics\, tackling COVID-19 within existing healthcare systems\, building health data platforms that support COVID-19 focused health care\, accommodating clinical trials in the era of COVID-19\, and developing functional vaccines and therapeutics. The next PMWC 2021 on January 25-27 would be a virtual conference and will touch upon these critical developments and ongoing activities while also including the regulatory and investment sides that influence clinical advancements.
URL:https://thebiocalendar.com/event/pmwc-covid/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210126T080000
DTEND;TZID=UTC:20210126T170000
DTSTAMP:20260609T131341
CREATED:20210127T062510Z
LAST-MODIFIED:20210127T062528Z
UID:1710-1611648000-1611680400@thebiocalendar.com
SUMMARY:Oscar
DESCRIPTION:Prueba
URL:https://thebiocalendar.com/event/oscar/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210126T094500
DTEND;TZID=UTC:20210128T170000
DTSTAMP:20260609T131341
CREATED:20210125T160000Z
LAST-MODIFIED:20201029T195935Z
UID:740-1611654300-1611853200@thebiocalendar.com
SUMMARY:Pharmacovigilance and Risk Management Strategies Conference
DESCRIPTION:DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the foundation for strong strategic planning and practical decision-making in your pharmacovigilance programs. Developed by recognized experts from the biopharmaceutical industry and global regulatory agencies\, this conference provides the background\, context\, and opportunities to discuss current challenges and to problem-solve around issues that matter most to professionals working in the field. \nThis year’s conference will address the current thinking on predicting and assessing risks such as drug-induced liver injury\, and the assessment of expectedness of serious adverse reactions during clinical development. The complexities of assessing benefit-risk balance of today’s therapies\, including immunotherapy and other advanced therapies\, will be examined. Experts will present approaches and engage in dialogs around more extensive and impactful uses of real world data and generation of RWE for safety assessments. A full day will be devoted to the development\, implementation\, and assessment of risk management strategies for drugs approved in multiple regions\, with a special in-depth coverage of REMS in the US. \nIn addition to new developments and updates on regional regulations and guidelines\, regulators from the US\, EU\, and other global regions provide the context and thinking behind evolving requirements. \n“One of the best conferences I have attended. A broad view on how far we have come in the world of PV\, why we do what we do\, and what is still to come ot meet future needs of patients and managing benefit-risk.” – Mary Welke\, Trilogy Writing & Consulting\, Inc \n\n\nWho should attend?\nProfessionals with intermediate to advanced knowledge of\, and experience in\, clinical safety and who are involved in: \n\nDrug Safety/Pharmacovigilance\nRisk Management\, including Risk Evaluation and Mitigation Strategies (REMS)\nBenefit-Risk Assessment and Communication\nMedical Product Safety Assessment\nRegulatory Affairs\nClinical Research\nPharmacoepidemiology\nPost-Market Studies and Real World Evidence Generation\nCustomer Engagement Programs\, including Patient Support Programs\nMedical Information\, Medical Communications\nHealth Outcomes\n\nIt is also designed for professionals who work for: \n\nIndustry: Pharmaceuticals\, Biologics\, Combination Products\, Devices\nClinical Research Organizations\, Contract Service Organizations\nAcademic Research Centers\nRegulatory Agencies\nGovernment Research Programs\n\nMembers of board\, C-level\, Senior Vice Presidents\, Vice Presidents\, Directors and Heads of departments from pharmaceutical involved in: \n\nDrug Safety\nPharmacovigilance\nRisk Management\nClinical Safety\nData management and data mining\nSafety & Risk Management\nSignal Detection\nRisk Management\nBenefit-Risk Assessment\nSafety Evaluation\nRegulatory Affairs\, Pharmacovigilance\nPV Governance\nSafety Surveillance\nPharmacovigilance Operations\nPV Inspection and Audit Readiness\nPatient Support Programs\nMarket Research Programs\nMedical Safety\nMedical Information\nPharmacoepidemiology
URL:https://thebiocalendar.com/event/pharmacovigilance-and-risk-management-strategies-conference/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2020/10/download-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20210126T110000
DTEND;TZID=UTC:20210126T200000
DTSTAMP:20260609T131341
CREATED:20201107T155747Z
LAST-MODIFIED:20201107T155747Z
UID:1277-1611658800-1611691200@thebiocalendar.com
SUMMARY:SV Global Investing Summit--Lifesciences Track
DESCRIPTION:You are invited to sign up and present at the next SV Global Investing Summit –Lifesciences Track on the 26th of January. You can visit pitchglobal.com for more details like the list of hundreds of investing firms which attends this Summit or visit the website of the Event Host\, Dr Fred Cohen\, Founding President of Keiretsu Forum(Pebble Beach Chapter). http://angeltoexit.com/GoToAngel.html
URL:https://thebiocalendar.com/event/sv-global-investing-summit-lifesciences-track/
END:VEVENT
END:VCALENDAR